Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab

PURPOSE: To compare using immuno-PET/CT the distribution of (89)Zr-labelled rituximab without and with a preload of unlabelled rituximab to assess the impact of preloading with unlabelled rituximab on tumour targeting and radiation dose of subsequent radioimmunotherapy with (90)Y-labelled rituximab...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Nucl Med Mol Imaging
Main Authors: Muylle, Kristoff, Flamen, Patrick, Vugts, Danielle J., Guiot, Thomas, Ghanem, Ghanem, Meuleman, Nathalie, Bourgeois, Pierre, Vanderlinden, Bruno, van Dongen, Guus A. M. S., Everaert, Hendrik, Vaes, Mélanie, Bron, Dominique
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2015
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4480335/
https://ncbi.nlm.nih.gov/pubmed/25792453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-015-3025-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares